Movement Disorders

Latest News

FDA logo on smartphone -- Image credit: gguy | stock.adobe.com
FDA Issues CRL to Vatiquinone NDA Indicated For Friedreich Ataxia

August 19th 2025

The complete response letter (CRL) stated that vatiquinone's new drug application (NDA) did not provide substantial evidence of efficacy and would need to be evaluated in a new trial.

Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care
Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care

June 8th 2025

Precision medicine in neurology -- Image credit: Evon J | stock.adobe.com
AAN 2025: Precision Medicine and Pharmacogenomics in Neurological Care

April 9th 2025

Close-up of elder man's hands with Parkinson disease, multiple system atrophy | mage Credit: © ipopba - stock.adobe.com
FDA Grants Orphan Drug Designation to Exidavnemab for Multiple System Atrophy

March 19th 2025

More News